Patients News | pharmaphorum

News

AstraZeneca China HQ: at Shanghai Zhangjiang Hi-Tech Park

China detains AstraZeneca workers in data, imports probe

AstraZeneca has confirmed that some of its current and former employees have been taken into custody in China as part of an investigation into data privacy breaches and the import of unlice

News

J&J sweetens controversial talc settlement deal

In a bid to put litigation over the safety of its talc products into the rearview mirror, Johnson & Johnson has added another $1.1 billion to its settlement offer, according to media re

News

Advanz wins stay on EU revocation of Ocaliva license

There's been another twist to the tale of Advanz Pharma's efforts to keep its primary biliary cholangitis (PBC) therapy Ocaliva on the market in the EU.

News

Novartis' oral PNH drug Fabhalta rolls out in England, Wales

Novartis' targeted Factor B inhibitor Fabhalta – the first oral monotherapy for rare disease paroxysmal nocturnal haemoglobinuria (PNH) – has been cleared by NICE for use by the NHS in Engl

News

Digital NHS health checks will start in England next year

A digital version of the NHS Health Check offered to older people in the UK will be piloted in some areas of England early next year, according to the government.

News

As mpox cases rise over 18,000, UNICEF tenders for vaccines

The United Nations Children's Fund (UNICEF) has issued an emergency tender to secure mpox vaccines for countries dealing with the brunt of the outbreak, in collaboration with the Gavi vacci

China detains AstraZeneca workers in data, imports probe

J&J sweetens controversial talc settlement deal

Advanz wins stay on EU revocation of Ocaliva license

Novartis' oral PNH drug Fabhalta rolls out in England, Wales

Digital NHS health checks will start in England next year

As mpox cases rise over 18,000, UNICEF tenders for vaccines

ESC26: Can Arrowhead pierce Ionis' triglyceride armour?

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks